The use of anti-obesity medications (AOMs) in adults have both surged and been widely studied
Shifting your mindset around food and weight loss is also crucial
During early treatment, follow-up may focus on digestive symptoms, hydration, food intake, and whether side effects interfere with daily life
The main difference is that tirzepatide often produces a larger caloric deficit due to stronger appetite suppression, which can cause more acute initial fatigue
Bioequivalence of Pharmacokinetic Endpoints Semaglutide dosing interval profiles at SS for each dose comparison (9 vs 14 mg [group 1], 4 vs 7 mg [group 2] and 1.5 vs 3 mg [group 3]) are shown in Fig
Backed by clinical research and proven patient results, Tirzepatide offers one of the most effective non-surgical solutions for achieving and maintaining a healthy weight